Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
A Randomized Clinical Trial of Infrared Coagulation Ablation Versus Active Monitoring of Intra-anal High-grade Dysplasia in Adults With Human Immunodeficiency Virus Infection: An AIDS Malignancy Consortium Trial
Abstract
Background
Anal high-grade squamous intraepithelial lesions (HSILs) ablation may reduce the
incidence of invasive cancer, but few data exist on treatment efficacy and natural
regression without treatment.
Methods
An open-label, randomized, multisite clinical trial of human immunodeficiency virus
(HIV)–infected adults aged ≥27 years with 1–3 biopsy-proven anal HSILs (index HSILs)
without prior history of HSIL treatment with infrared coagulation (IRC). Participants
were randomized 1:1 to HSIL ablation with IRC (treatment) or no treatment (active
monitoring [AM]). Participants were followed every 3 months with high-resolution
anoscopy. Treatment participants underwent anal biopsies of suspected new or recurrent
HSILs. The AM participants underwent biopsies only at month 12. The primary end point
was complete clearance of index HSIL at month 12.
Results
We randomized 120 participants. Complete index HSIL clearance occurred more frequently
in the treatment group than in the AM (62% vs 30%; risk difference, 32%; 95% confidence
interval [CI], 13%–48%; P < .001). Complete or partial clearance (clearance of ≥1
index HSIL) occurred more commonly in the treatment group (82% vs 47%; risk difference,
35%; 95% CI, 16%–50%; P < .001). Having a single index lesion, compared with having
2–3 lesions, was significantly associated with complete clearance (relative risk, 1.96;
95% CI, 1.22–3.10). The most common adverse events related to treatment were mild or
moderate anal pain and bleeding. No serious adverse events were deemed related to
treatment or study participation.
Conclusion
IRC ablation of anal HSILs results in more clearance of HSILs than observation
alone.
Ablation of anal canal high-grade squamous intraepithelial lesions (HSILs) is more likely
to result in a complete or partial resolution of HSILs than monitoring alone. Spontaneous
HSIL regression occurred, and a 1-year delay in treatment did not affect ultimate
outcomes.